Tirupati Starch & Chemicals Ltd
Incorporated in 1985, Tirupati Starch & Chemicals Ltd manufactures Starch, Dextrose Anhydrous, and other Products[1]
- Market Cap ₹ 167 Cr.
- Current Price ₹ 174
- High / Low ₹ 219 / 140
- Stock P/E 15.7
- Book Value ₹ 65.1
- Dividend Yield 0.00 %
- ROCE 10.4 %
- ROE 13.2 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.67 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of 7.29% over past five years.
- Company has a low return on equity of 10.9% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61 | 59 | 158 | 177 | 199 | 227 | 271 | 200 | 318 | 364 | 306 | 386 | 378 | |
| 58 | 55 | 152 | 169 | 189 | 216 | 263 | 191 | 298 | 343 | 285 | 361 | 350 | |
| Operating Profit | 3 | 4 | 6 | 8 | 10 | 11 | 8 | 9 | 19 | 21 | 20 | 25 | 28 |
| OPM % | 5% | 6% | 4% | 4% | 5% | 5% | 3% | 5% | 6% | 6% | 7% | 6% | 7% |
| 0 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 2 | 1 | 0 | 4 | 4 | |
| Interest | 1 | 1 | 6 | 5 | 4 | 3 | 2 | 3 | 6 | 8 | 10 | 11 | 11 |
| Depreciation | 1 | 2 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 8 | 8 | 8 |
| Profit before tax | 2 | 1 | -5 | 0 | 2 | 4 | 2 | 1 | 9 | 8 | 3 | 10 | 14 |
| Tax % | 25% | 193% | -67% | -3,700% | 21% | 21% | 26% | 4% | 12% | 14% | 32% | 26% | |
| 1 | -1 | -2 | 1 | 2 | 3 | 1 | 1 | 8 | 7 | 2 | 8 | 11 | |
| EPS in Rs | 1.95 | -1.95 | -2.48 | 1.87 | 2.90 | 5.32 | 1.89 | 1.47 | 11.80 | 8.12 | 2.16 | 7.86 | 11.09 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 7% |
| 3 Years: | 7% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 46% |
| 3 Years: | -3% |
| TTM: | 15086% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 39% |
| 3 Years: | 35% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 12% |
| 3 Years: | 11% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 8 | 10 | 10 | 10 |
| Reserves | 7 | 6 | 4 | 7 | 11 | 15 | 16 | 21 | 29 | 38 | 44 | 51 | 53 |
| 39 | 44 | 54 | 49 | 26 | 23 | 22 | 55 | 77 | 90 | 154 | 136 | 136 | |
| 4 | 27 | 40 | 44 | 65 | 94 | 96 | 51 | 45 | 33 | 19 | 34 | 37 | |
| Total Liabilities | 57 | 82 | 105 | 107 | 109 | 138 | 140 | 133 | 158 | 169 | 226 | 230 | 235 |
| 6 | 61 | 59 | 64 | 65 | 60 | 55 | 71 | 61 | 55 | 93 | 98 | 92 | |
| CWIP | 33 | 0 | 4 | 0 | 0 | 9 | 18 | 7 | 16 | 46 | 27 | 40 | 44 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| 18 | 21 | 43 | 42 | 44 | 69 | 66 | 55 | 80 | 68 | 107 | 91 | 98 | |
| Total Assets | 57 | 82 | 105 | 107 | 109 | 138 | 140 | 133 | 158 | 169 | 226 | 230 | 235 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | 17 | -4 | 14 | 33 | 5 | 12 | -35 | -1 | 23 | -34 | 49 | |
| -21 | -20 | -6 | -5 | -5 | -9 | -9 | -6 | -6 | -25 | -32 | -26 | |
| 18 | 3 | 10 | -8 | -28 | 4 | -3 | 41 | 7 | 9 | 59 | -24 | |
| Net Cash Flow | 0 | 0 | -0 | -0 | 0 | 0 | -0 | -0 | -0 | 8 | -7 | -1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 27 | 45 | 44 | 36 | 38 | 61 | 37 | 45 | 35 | 33 | 41 | 37 |
| Inventory Days | 68 | 112 | 55 | 43 | 33 | 41 | 48 | 39 | 54 | 19 | 83 | 54 |
| Days Payable | 27 | 223 | 89 | 58 | 54 | 99 | 154 | 90 | 55 | 30 | 13 | 24 |
| Cash Conversion Cycle | 69 | -66 | 10 | 20 | 17 | 2 | -69 | -6 | 33 | 22 | 111 | 68 |
| Working Capital Days | 25 | -118 | -24 | 10 | 6 | 14 | -51 | 0 | 21 | -2 | 23 | -5 |
| ROCE % | 6% | 5% | 3% | 6% | 12% | 15% | 9% | 7% | 16% | 13% | 8% | 10% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
17 Nov - Submission of Newspapers Publication for Un-audited Financial Results of the Company for Quarter and Half Year ended on 30.09.2025
- Corrigendum To Un-Audited Consolidated Financial Results For The Quarter And Half Year Ended On 30.09.2025 14 Nov
- Submission Of Standalone & Consolidated Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended On 30.09.2025 14 Nov
-
Board Meeting Outcome for Outcome Of Board Meeting
14 Nov - Approved unaudited standalone and consolidated Q2/H1 results for September 30, 2025; committees reconstituted.
-
Report On Re-Lodgments Of Transfer Requests Of Physical Shares
10 Nov - October 2025 re-lodgement report: 1 request received, 0 processed/approved, 1 rejected; average processing time 3 days.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Profile:[1][2]
a) Main Products:
Maize Starch Powder, Dextrose Anhydrous, Dextrose Monohydrate, Dextrin (White & Yellow), IP Starch, Liquid Glucose, Tyrolese, Vervosize
b) By Products:
Hydrol, Maize Bran, Maize Cattle Feed, Grit, Maize Germ, Maize Gluten, Maize Husk Dry/ Wet, Corn Gluten, and Corn Gem